Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

WRBY vs DBVT vs ALKS vs NVST

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WRBY
Warby Parker Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$3.34B
5Y Perf.-48.7%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-59.2%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+14.8%
NVST
Envista Holdings Corp

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$4.04B
5Y Perf.-41.9%

WRBY vs DBVT vs ALKS vs NVST — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WRBY logoWRBY
DBVT logoDBVT
ALKS logoALKS
NVST logoNVST
IndustryMedical - Instruments & SuppliesBiotechnologyBiotechnologyMedical - Equipment & Services
Market Cap$3.34B$1712.35T$5.90B$4.04B
Revenue (TTM)$891M$0.00$1.56B$2.81B
Net Income (TTM)$1M$-168M$153M$68M
Gross Margin53.4%65.4%55.1%
Operating Margin-0.7%12.3%9.0%
Forward P/E56.7x24.8x17.2x
Total Debt$233M$22M$70M$1.71B
Cash & Equiv.$286M$194M$1.12B$1.21B

WRBY vs DBVT vs ALKS vs NVSTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WRBY
DBVT
ALKS
NVST
StockSep 21May 26Return
Warby Parker Inc. (WRBY)10051.3-48.7%
DBV Technologies S.… (DBVT)10040.8-59.2%
Alkermes plc (ALKS)100114.8+14.8%
Envista Holdings Co… (NVST)10058.1-41.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: WRBY vs DBVT vs ALKS vs NVST

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Warby Parker Inc. is the stronger pick specifically for growth and revenue expansion. DBVT and NVST also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
WRBY
Warby Parker Inc.
The Growth Play

WRBY is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 13.0%, EPS growth 107.7%, 3Y rev CAGR 13.4%
  • 13.0% revenue growth vs DBVT's -100.0%
Best for: growth exposure
DBVT
DBV Technologies S.A.
The Income Pick

DBVT is the clearest fit if your priority is income & stability.

  • Dividend streak 0 yrs, beta 1.26
  • +110.4% vs ALKS's +16.5%
Best for: income & stability
ALKS
Alkermes plc
The Long-Run Compounder

ALKS carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • -11.0% 10Y total return vs NVST's -13.1%
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • 9.8% margin vs WRBY's 0.2%
Best for: long-term compounding and sleep-well-at-night
NVST
Envista Holdings Corp
The Value Play

NVST is the clearest fit if your priority is value.

  • Better valuation composite
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthWRBY logoWRBY13.0% revenue growth vs DBVT's -100.0%
ValueNVST logoNVSTBetter valuation composite
Quality / MarginsALKS logoALKS9.8% margin vs WRBY's 0.2%
Stability / SafetyALKS logoALKSBeta 1.06 vs WRBY's 2.22, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs ALKS's +16.5%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

WRBY vs DBVT vs ALKS vs NVST — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WRBYWarby Parker Inc.
FY 2025
Eyewear Products
92.8%$719M
Services And Other
7.2%$56M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
NVSTEnvista Holdings Corp
FY 2024
Specialty Products and Technologies
64.4%$1.6B
Equipment and Consumables
35.6%$894M

WRBY vs DBVT vs ALKS vs NVST — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 5 of 6 comparable metrics.

NVST and DBVT operate at a comparable scale, with $2.8B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to WRBY's 0.2%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWRBY logoWRBYWarby Parker Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNVST logoNVSTEnvista Holdings …
RevenueTrailing 12 months$891M$0$1.6B$2.8B
EBITDAEarnings before interest/tax$32M-$112M$212M$342M
Net IncomeAfter-tax profit$1M-$168M$153M$68M
Free Cash FlowCash after capex$39M-$151M$392M$220M
Gross MarginGross profit ÷ Revenue+53.4%+65.4%+55.1%
Operating MarginEBIT ÷ Revenue-0.7%+12.3%+9.0%
Net MarginNet income ÷ Revenue+0.2%+9.8%+2.4%
FCF MarginFCF ÷ Revenue+4.4%+25.1%+7.8%
Rev. Growth (YoY)Latest quarter vs prior year+8.3%+28.2%+14.4%
EPS Growth (YoY)Latest quarter vs prior year+7.5%+91.5%-4.1%+130.0%
ALKS leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

NVST leads this category, winning 3 of 6 comparable metrics.

At 24.8x trailing earnings, ALKS trades at a 99% valuation discount to WRBY's 2076.3x P/E. On an enterprise value basis, NVST's 13.3x EV/EBITDA is more attractive than WRBY's 73.1x.

MetricWRBY logoWRBYWarby Parker Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNVST logoNVSTEnvista Holdings …
Market CapShares × price$3.3B$1712.35T$5.9B$4.0B
Enterprise ValueMkt cap + debt − cash$3.3B$1712.35T$4.9B$4.5B
Trailing P/EPrice ÷ TTM EPS2076.34x-0.76x24.76x86.73x
Forward P/EPrice ÷ next-FY EPS est.56.75x17.21x
PEG RatioP/E ÷ EPS growth rate58.08x
EV / EBITDAEnterprise value multiple73.08x17.25x13.28x
Price / SalesMarket cap ÷ Revenue3.83x4.00x1.49x
Price / BookPrice ÷ Book value/share9.25x0.66x3.28x1.32x
Price / FCFMarket cap ÷ FCF76.32x12.28x17.54x
NVST leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to WRBY's 0.63x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs DBVT's 4/9, reflecting strong financial health.

MetricWRBY logoWRBYWarby Parker Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNVST logoNVSTEnvista Holdings …
ROE (TTM)Return on equity+0.4%-130.2%+8.8%+2.2%
ROA (TTM)Return on assets+0.2%-89.0%+5.4%+1.2%
ROICReturn on invested capital-1.3%+18.9%+4.8%
ROCEReturn on capital employed-1.0%-145.7%+14.2%+4.9%
Piotroski ScoreFundamental quality 0–96477
Debt / EquityFinancial leverage0.63x0.13x0.04x0.55x
Net DebtTotal debt minus cash-$53M-$172M-$1.0B$496M
Cash & Equiv.Liquid assets$286M$194M$1.1B$1.2B
Total DebtShort + long-term debt$233M$22M$70M$1.7B
Interest CoverageEBIT ÷ Interest expense-189.82x32.30x12.76x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ALKS leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs ALKS's +16.5%. The 3-year compound annual growth rate (CAGR) favors WRBY at 31.0% vs NVST's -11.3% — a key indicator of consistent wealth creation.

MetricWRBY logoWRBYWarby Parker Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNVST logoNVSTEnvista Holdings …
YTD ReturnYear-to-date+20.2%+4.9%+25.3%+12.0%
1-Year ReturnPast 12 months+68.3%+110.4%+16.5%+44.2%
3-Year ReturnCumulative with dividends+125.0%+19.7%+14.5%-30.3%
5-Year ReturnCumulative with dividends-50.1%-69.1%+60.9%-46.6%
10-Year ReturnCumulative with dividends-50.1%-87.0%-11.0%-13.1%
CAGR (3Y)Annualised 3-year return+31.0%+6.2%+4.6%-11.3%
ALKS leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than WRBY's 2.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs DBVT's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWRBY logoWRBYWarby Parker Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNVST logoNVSTEnvista Holdings …
Beta (5Y)Sensitivity to S&P 5002.22x1.26x1.06x1.65x
52-Week HighHighest price in past year$31.00$26.18$36.60$30.42
52-Week LowLowest price in past year$14.96$7.53$25.17$16.33
% of 52W HighCurrent price vs 52-week peak+87.7%+76.3%+96.7%+79.8%
RSI (14)Momentum oscillator 0–10046.648.160.255.1
Avg Volume (50D)Average daily shares traded2.8M252K2.3M2.4M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: WRBY as "Buy", DBVT as "Buy", ALKS as "Buy", NVST as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 7.8% for WRBY (target: $29).

MetricWRBY logoWRBYWarby Parker Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNVST logoNVSTEnvista Holdings …
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$29.33$46.33$44.00$27.00
# AnalystsCovering analysts15152819
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises00
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%+4.1%
Insufficient data to determine a leader in this category.
Key Takeaway

ALKS leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NVST leads in 1 (Valuation Metrics).

Best OverallAlkermes plc (ALKS)Leads 4 of 6 categories
Loading custom metrics...

WRBY vs DBVT vs ALKS vs NVST: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is WRBY or DBVT or ALKS or NVST a better buy right now?

For growth investors, Warby Parker Inc.

(WRBY) is the stronger pick with 13. 0% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate Warby Parker Inc. (WRBY) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WRBY or DBVT or ALKS or NVST?

On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.

8x versus Warby Parker Inc. at 2076. 3x. On forward P/E, Envista Holdings Corp is actually cheaper at 17. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — WRBY or DBVT or ALKS or NVST?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: ALKS returned -11. 0% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WRBY or DBVT or ALKS or NVST?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus Warby Parker Inc. 's 2. 22β — meaning WRBY is approximately 109% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 63% for Warby Parker Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — WRBY or DBVT or ALKS or NVST?

By revenue growth (latest reported year), Warby Parker Inc.

(WRBY) is pulling ahead at 13. 0% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Warby Parker Inc. grew EPS 107. 7% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, WRBY leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WRBY or DBVT or ALKS or NVST?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -0. 6% for WRBY. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WRBY or DBVT or ALKS or NVST more undervalued right now?

On forward earnings alone, Envista Holdings Corp (NVST) trades at 17.

2x forward P/E versus 56. 7x for Warby Parker Inc. — 39. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — WRBY or DBVT or ALKS or NVST?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is WRBY or DBVT or ALKS or NVST better for a retirement portfolio?

For long-horizon retirement investors, Alkermes plc (ALKS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

06)). Warby Parker Inc. (WRBY) carries a higher beta of 2. 22 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALKS: -11. 0%, WRBY: -50. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WRBY and DBVT and ALKS and NVST?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

WRBY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 32%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

NVST

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.